GeoNova Capital Announces Cornerstone Investment in NovaGen Following Proposed Business Combination with Veea
GeoNova Capital has committed US$10 million as a lead investor and corporate adviser to NovaGen Group B.V. following its proposed business combination with Nasdaq-listed Veea Inc. (NASDAQ: VEEA). The two companies have signed a non-binding term sheet for the transaction, which aims to create NovaGen Health Networks—a longevity and precision-health platform combining AI infrastructure from Veea with cellular-reprogramming science from NovaGen. GeoNova is structuring the financing around this Nasdaq listing opportunity and has invited co-investment opportunities. The firm emphasized its role in accelerating transformational business changes by providing both capital and strategic guidance, positioning itself as a key player in event-driven investing across sectors like healthcare, biotechnology, AI, defense, and natural resources. GeoNova is also actively seeking new public-market opportunities with an identifiable catalyst for growth or listing. The proposed transaction remains subject to definitive documentation, regulatory approvals, and customary closing conditions.
Topics: Business Combination Capital Markets Healthcare Tech Investment